Discoveries in Health Policy

Ideas for or from an evolving healthcare system

Sunday, October 4, 2026

Understanding Sparano via Understanding the "C Statistic"

›
The adjacent blog about the Oncotype test and Sparano's new IICM+ test, pivots almost every quantitative comparison on "C-statistic...

Is Sparano et al. Better than Oncotype DX? New Publication.

›
From time to time a test is published as "Better than Oncotype Dx," which has been around since about 2004. Some have even been ba...

Case Study: The Border Between Wellness Devices, Medical @Home Devices, and Coding

›
 What happens when a $299 wristband challenges a medical service built around much more expensive equipment?  In this fictional business sch...
Friday, October 2, 2026

What Cancer Payment Rewards, and What Gets Left Behind: Shah 2026 in JAMA Oncol.

›
 In a new article at JAMA Oncology Shah describes two treatments - one superior - and then reveals we pay $100,000 for the less useful thin...

When AI Beats Google: Agentic AI Searchs for Media about "14 Day Rule"

›
The "14 day rule" for CMS lab specimens is pretty obscure.  I asked Chat GPT to search the internet for media, op eds, etc, on 14 ...
Tuesday, September 29, 2026

CMS Releases Pricing Proposals for 110 New 2027 Lab Codes

›
 CMS has released its 110 proposals for new lab codes for 2027.  On this web page , scroll down for Agendas and Important Materials to find ...

MolDx: Final Gapfill Pricing for CY2027

›
The gapfill year has run its course for 17 codes. We saw proposed prices in May, final pries in September.  Five codes changed price (althou...

Digital Pathology Update: Signals from Leica, from CAP TODAY, from Mayo

›
 [AI generated, Chat GPT 5.6] [Links at bottom] ## Future of Digital Pathology: Signals from Leica, Mayo, and CAP TODAY Digital pathology’s ...

Date of Service Rule for Inpatients: Does It Conflict with Other Regulations?

›
The Medicare Date of Service rule defines "date of specimen collection" as the "date of service" - for inpatients, unles...
Monday, September 28, 2026

The Distribution of PAMA Prices: Case Study 81455, 81456 (51 or more tumor genes)

›
CMS has released a new clin lab fee schedule for 2027-2028-2029.   Price cuts were common, based on reported private payer pricing data.  (G...
Friday, September 25, 2026

LegislationWatch: ASAP (Alzheimer Tests), MAIA, PACA, PPA (all for Medicare Advantage Claims)

›
 ALZHEIMER ON THE HILL On September 16, 2026, the House Ways and Means committee advanced a bipartisan Alzheimer bill , "Alzheimer'...

Very Brief Blog: John Warren Highlights "Genealogy of Pricing" as Key to Crosswalks

›
In an excellent Linked In posting, CMS consultant John Warren emphasizes that you can't do crosswalks and gapfill decisions any more, wi...
Thursday, September 24, 2026

Cheat Sheet: The Six Publications About GRAIL (Released Concurrent with FDA Ad Comm)

›
We just had the Ad Comm for GRAIL - whose stock nearly doubled from 9/17 to 9/24.  Market cap rising from $2.5B to $5.5B.   You'll be ex...
›
Home
View web version

About the Author

My photo
Bruce
Bruce Quinn MD PhD is an expert on health reform, innovation, and Medicare policy. He helps both large and small companies understand and overcome hurdles to commercialization, as well as craft business strategies for a changing environment. CONTACT Dr. Quinn through www.brucequinn.com. BACKGROUND: Dr. Quinn has worked in academic medicine, Accenture business strategies, and for the Medicare program. EDUCATION: Stanford MD/PhD, MIT Postdoc, Kellogg MBA.
View my complete profile
Powered by Blogger.